Back
Janux Therapeutics, Inc. Stock Predictions
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
32
JANX
Janux Therapeutics, Inc.
Last Price:
$16.39
Seasonality Move:
94.45%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiJanux Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Janux Therapeutics, Inc. has on average historically risen by 59.6% based on the past 4 years of stock performance.
-
Janux Therapeutics, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is Janux Therapeutics, Inc. Stock Undervalued?The current Janux Therapeutics, Inc. [JANX] share price is $16.40. The Score for JANX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Janux Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Janux Therapeutics, Inc. has on average historically risen by 59.6% based on the past 4 years of stock performance.
Janux Therapeutics, Inc. Stock Rating
Sell
32
Janux Therapeutics, Inc. (JANX)
is a Sell
Is Janux Therapeutics, Inc. overpriced?
-
Janux Therapeutics, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Janux Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
januxrx.com
52-Week Data
52-Week High:
71.71
52-Week Low:
15.51
Prediction Charts
Market Cap:
986.4M
Price in USD:
16.40
Volume:
2.5M
Beta:
2.87
Technical Analysis
SMA50:
26.66
SMA100:
25.50
SMA200:
26.55
52-Wk Change:
-75.46%
Stock Predictions
-
Is Janux Therapeutics, Inc. stock public?Yes, Janux Therapeutics, Inc. is a publicly traded company.
-
What is the Janux Therapeutics, Inc. stock quote today?The Janux Therapeutics, Inc. stock price is 16.40 USD today.
-
How to buy Janux Therapeutics, Inc. stock online?You can buy Janux Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 27.01 | 29.28 | 30.47 | 27.01 |
| Nov-17 | 28.95 | 28.72 | 29.94 | 28.34 |
| Nov-18 | 27.95 | 29.02 | 29.45 | 27.67 |
| Nov-19 | 28.57 | 28.81 | 30.09 | 28.51 |
| Nov-20 | 29.29 | 28.59 | 30.23 | 28.25 |
| Nov-21 | 28.60 | 28.80 | 30.19 | 28.39 |
| Nov-24 | 29.04 | 31.53 | 31.57 | 28.98 |
| Nov-25 | 32.19 | 34.74 | 35.00 | 31.75 |
| Nov-26 | 34.42 | 34.69 | 35.34 | 33.20 |
| Nov-28 | 34.67 | 34.09 | 35.25 | 33.65 |
| Dec-1 | 34.04 | 33.99 | 34.04 | 32.10 |
| Dec-2 | 18.51 | 15.86 | 18.86 | 15.77 |
| Dec-3 | 15.97 | 17.11 | 17.37 | 15.51 |
| Dec-4 | 17.05 | 16.40 | 17.22 | 16.30 |
Janux Therapeutics, Inc. Earnings
Janux Therapeutics, Inc. Earnings Report: Per Share Janux Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Janux Therapeutics, Inc. Forecast Revenue Growth
Janux Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Janux Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.67 per share, and a decrease next year of $1.00 per share.
* Janux Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.